|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/50 | |||
| A61K 47/26 | |||
| A61K 39/395 | |||
| A61K 38/17 | |||
| A61L 27/50 |
| (11) | Number of the document | 3452013 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17793162.3 |
| Date of filing the European patent application | 2017-05-02 | |
| (97) | Date of publication of the European application | 2019-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/030642 |
| Date | 2017-05-02 |
| (87) | Number | WO 2017/192590 |
| Date | 2017-11-09 |
| (30) | Number | Date | Country code |
| 201662330592 P | 2016-05-02 | US |
| (72) |
SCHWENDEMAN, Steven P., US
CHANG, Rae Sung, US
|
| (73) |
The Regents of The University of Michigan,
Office of Technology Transfer 1600 Huron Parkway, 2nd Floor, Ann Arbor, MI 48109-2590,
US
|
| (54) | COATED IMPLANTS FOR LONG-TERM CONTROLLED RELEASE OF ANTIBODY THERAPEUTICS |
| COATED IMPLANTS FOR LONG-TERM CONTROLLED RELEASE OF ANTIBODY THERAPEUTICS |